Skip to main content

Table 1 Baseline characteristics and biochemical assessments

From: Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes

Variable Control group (n = 83) CAD group (n = 241) P value
Men (%) 38(45.8) 165(68.5) <0.0001
Age (yrs) 62 ± 10 66 ± 10 0.001
Cigarette smoking (%) 11(13.3) 68(28.2) 0.007
Hypertension (%) 52(62.7) 175(72.6) NS
Blood pressure
   Systolic (mmHg) 138 ± 21 137 ± 20 NS
   Diastolic (mmHg) 81 ± 10 79 ± 11 NS
   Hyperlipidemia (%) 47(56.6) 137(56.8) NS
Cholesterol
   Total cholesterol (mmol/L) 4.77 ± 1.27 4.70 ± 1.15 NS
   HDL-cholesterol (mmol/L) 1.19 ± 0.30 1.13 ± 0.41 NS
   LDL-cholesterol (mmol/L) 2.80 ± 0.89 2.73 ± 0.90 NS
Triglycerides(mmol/L) 2.23 ± 1.79 2.01 ± 1.19 NS
Lipoprotein-a (g/L) 0.19 ± 0.11 0.25 ± 0.19 0.025
Apo-A (g/L) 1.29 ± 0.19 1.24 ± 0.22 NS
Apo-B (g/L) 0.94 ± 0.26 0.94 ± 0.25 NS
Glucose (mmol/L) 7.03 ± 1.88 7.28 ± 2.72 NS
Blood urea nitrogen (mmol/L) 5.49 ± 1.60 6.05 ± 2.29 0.043
Creatinine (μmol/L) 74.67 ± 16.31 92.59 ± 29.22 <0.0001
Uric acid (μmol/L) 307.9 ± 76.03 314.19 ± 83.07 NS
Glycated albumin (%) 19.37 ± 4.29 21.21 ± 5.24 0.001
Hs-CRP (mg/L) 7.37 ± 8.71 25.77 ± 30.35 <0.0001